Everolimus-Based Immunosuppression in Liver Transplant Recipients

被引：2
|
作者：
Saliba, F. [1 ]
机构：
[1] Hop Paul Brousse, AP HP, Ctr Hepatobiliaire, INSERM,Unite 1193, Villejuif, France
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2017年 / 17卷 / 09期
关键词：
D O I：
10.1111/ajt.14388
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：2489 / 2489
页数：1
相关论文
共 50 条
  • [31] Time to Conversion to an Everolimus-Based Regimen: Renal Outcomes in Liver Transplant Recipients From the EVEROLIVER Registry
    Saliba, Faouzi
    Dharancy, Sebastien
    Salame, Ephrem
    Conti, Filomena
    Eyraud, Daniel
    Radenne, Sylvie
    Antonini, Teresa
    Guillaud, Olivier
    Guguenheim, Jean
    Neau-Cransac, Martine
    Demartin, Eleonora
    Lasailly, Guillaume
    Duvoux, Christophe
    Sobesky, Rodolphe
    Coilly, Audrey
    Tresson, Sylvie
    Cailliez, Valerie
    Boillot, Olivier
    Pageaux, Georges Philippe
    Samuel, Didier
    Calmus, Yvon
    Dumortier, Jerome
    LIVER TRANSPLANTATION, 2020, 26 (11) : 1465 - 1476
  • [32] Cytomegalovirus disease in de novo kidney-transplant recipients: comparison of everolimus-based immunosuppression without prophylaxis with mycophenolic acid-based immunosuppression with prophylaxis
    Maniere, Louis
    Noble, Johan
    Terrec, Florian
    Bennani, Hamza Naciri
    Chevallier, Eloi
    Janbon, Benedicte
    Germi, Raphaele
    Bugnazet, Mathilde
    Imerzoukene, Farida
    Malvezzi, Paolo
    Rostaing, Lionel
    Jouve, Thomas
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2021, 53 (03) : 591 - 600
  • [33] Rapid Achievement of Therapeutic Levels and Exposure-Efficacy Analysis in De Novo Cardiac Transplant Recipients on Everolimus-Based Immunosuppression
    Livi, U.
    Arizon, J.
    Mattei, M. -F
    Musumeci, F.
    Maccherini, M.
    Almenar, L.
    Delgado, J.
    Kleinloog, R.
    Li, Y.
    Lebmkuhl, H.
    Flocchi, R.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2009, 28 (02): : S307 - S307
  • [34] Utility of immune monitoring in heart transplant recipients on everolimus-based immune suppression
    Ben Gal, Tuvia
    Israeli, Moshe
    Yaari, Victoria
    Hasdai, David
    Matz, Israel
    Yussim, Alexander
    Battler, Alexander
    Klein, Tirza
    Medalion, Benjamin
    CLINICAL TRANSPLANTATION, 2014, 28 (04) : 428 - 433
  • [35] Cytomegalovirus disease in de novo kidney-transplant recipients: comparison of everolimus-based immunosuppression without prophylaxis with mycophenolic acid-based immunosuppression with prophylaxis
    Louis Manière
    Johan Noble
    Florian Terrec
    Hamza Naciri Bennani
    Eloi Chevallier
    Bénédicte Janbon
    Raphaele Germi
    Mathilde Bugnazet
    Farida Imerzoukene
    Paolo Malvezzi
    Lionel Rostaing
    Thomas Jouve
    International Urology and Nephrology, 2021, 53 : 591 - 600
  • [36] Everolimus-based immunosuppressive regimens in lung transplant recipients: Impact on CMV infection
    Ritta, Massimo
    Costa, Cristina
    Solidoro, Paolo
    Sidoti, Francesca
    Libertucci, Daniela
    Boffini, Massimo
    Rinaldi, Mauro
    Baldi, Sergio
    Cavallo, Rossana
    ANTIVIRAL RESEARCH, 2015, 113 : 19 - 26
  • [37] Achieving Therapeutic Levels and Exposure-Efficacy Analysis in De Novo Cardiac Transplant Recipients on Everolimus-Based Immunosuppression.
    Musumeci, Francesco
    Livi, Ugolino
    Arizon, Jose
    Mattei, Marie Franoise
    Maccherini, Massimo
    Almenar, Luis
    Delgado, Juan F.
    Keinloog, Robert
    Gezahegen, Yonas A.
    Li, Yulan
    Lehmkuhl, Hans
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 246 - 246
  • [38] Renal Recovery After Conversion to an Everolimus-Based Immunosuppression in Early and Late Heart Transplant Recipients: A 12-Month Analysis
    Michel, Sebastian
    Bigdeli, Amir Khosrow
    Hagl, Christian
    Meiser, Bruno
    Kaczmarek, Ingo
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2013, 11 (05) : 429 - 434
  • [39] Immunosuppression Based on Everolimus in Liver Transplant Recipients With Severe Early Post-transplantation Neurotoxicity
    Bilbao, I.
    Dopazo, C.
    Castells, L.
    Lazaro, J.
    Caralt, M.
    Sapisochin, G.
    Charco, R.
    TRANSPLANTATION PROCEEDINGS, 2014, 46 (09) : 3104 - 3107
  • [40] Efficacy and Safety of Everolimus Based Immunosuppression in HCV Positive De Novo Liver Transplant Recipients
    Saliba, F.
    De Simone, P.
    De Carlis, L.
    Metselaar, H. J.
    Beckebaum, S.
    Jonas, S.
    Sudan, D.
    Fung, J.
    Fischer, L.
    Huang, M. A.
    Foltys, D.
    Wang, Y.
    Sips, C.
    Lopez, P.
    Nevens, F.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 125 - 126
12345